"I was thinking must be important 3 of them in the same

New Post Public Reply Private Reply Replies (1) Message Board
HHIGambler misiu143 #2952
286
"I was thinking must be important 3 of them in the same place for 2 days."

I agree, Misiu. NP has been telling us for the last month or so that we're very close to a licensing deal. Yesterday's discounting of the warrants is not a "licensing deal". The main value of the warrants to the company is they provide cash to the company when exercised. Assuming that a licensing deal is still in the works, we still need the cash now - not in 6 months. And I doubt this was just NP's idea - I suspect Klump was heavily behind this plan and I think it's a great way to flush our the warrants and generate the much needed cash, and at a time when we need it the most. It's a win-win strategy! The sp will jump back up by the time they close the deal on 6/12 and announce the amount of cash raised, and I would be very surprised if it's not north of $25mil.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ACE Money Transfer Expands into European Markets from Ireland

Updated Category News Views 141

ACE Money Transfer's European Expansion Journey Ace Money Transfer is embarking on an exciting new adventure by expanding its services into Europe, with Ireland as its strategic base. This initiative aims to reshape the remittance landscape across the continent, building on the company's robust foundation established in Ireland. Why Ireland is the Launchpad for Growth...

Continue Reading
Legal Opportunity for BioAge Labs Investors Awaits Action

Updated Category News Views 90

Investors Prepare for Class Action Against BioAge Labs Investors in BioAge Labs, Inc. (NASDAQ: BIOA) have been alerted to an upcoming opportunity to take part in a securities class action lawsuit. This comes from the Rosen Law Firm, a global advocate for investor rights. The firm is advocating for those who purchased shares of BioAge during its initial public offering...

Continue Reading
Iveda Partners with Data Management to Advance Sustainability

Updated Category News Views 41

Iveda's Strategic Partnership to Enhance Sustainability Iveda, a leader in cloud-based AI technology, is partnering with Data Management, renowned for its expertise in disaster recovery services, to reduce carbon emissions and improve energy efficiency. This collaboration utilizes IvedaEMS, an advanced Energy Management System (EMS) that cleverly employs smart meters to...

Continue Reading
IPSEN Reports on Recent Share Buy-Back Activities in 2025

Updated Category News Views 156

Overview of IPSEN's Share Buy-Back Program IPSEN has been actively engaged in its share buy-back program, which reflects the company's commitment to maximizing shareholder value. The program is a strategic move to enhance EPS and demonstrate confidence in the business's long-term prospects. This article will delve into the specifics of transactions executed during a...

Continue Reading
Turkey's Central Bank Steadfast Amid Inflation Concerns

Updated Category News Views 72

Turkey's Central Bank Stays the Course at 50% Rate Turkey's central bank has opted to keep its policy rate steady at 50%. This decision aligns with market expectations as the institution continues to monitor inflation risks closely. Analysis of Central Bank's Position Following the monetary policy committee meeting, the central bank emphasized that the policy rate would...

Continue Reading